期刊文献+

乌鲁木齐市门诊非瓣膜性心房颤动患者INR控制现况调查 被引量:3

下载PDF
导出
摘要 目的 了解乌鲁木齐市二、三级医院心血管内科门诊慢性非瓣膜性心房颤动患者国际标准化比例(INR)控制现状.方法 调查2011-08 ~2011-12在乌鲁木齐市2家三级医院和2家二级医院心内科门诊就医的慢性非瓣膜性心房颤动(房颤)患者467例,所有患者均完成调查问卷(包括患者一般情况、合并其他疾病情况、房颤抗凝知识及华法令使用情况),同时观察凝血功能,分析INR达标情况及影响因素. 结果 共收到有效调查问卷467份,男性264例(56.53%),女性203例(43.5%);年龄(62.9±7.9)岁.房颤患者INR达标率11.5% (36/312),二级医院INR达标率低于三级医院(6.8%vs15.7%,P <0.05);女性患者达标率低于男性(9.4%vs13.4%,P<0.05);大于75岁患者达标率低于小于75岁患者男性(4.6%vs13.4%,P<0.05);脑卒中患者达标率低于无脑卒中患者(6.5%vs13.3%,P<0.05),INR达标率在是否高血压、糖尿病、心力衰竭或吸烟、了解INR目标值、定期监测凝血功能之间差异无统计学意义(均P>0.05).有59.5%的患者未使用或停用华法令,在未使用华法令的原因中:177例(69.4%)与医生未开处方有关,14.2%为患者自行停用华法令. 结论 乌鲁木齐地区房颤患者INR达标率较低,要加强基层医院医师对房颤抗凝知识的培训,并加强对患者房颤抗凝知识健康教育,提高治疗的依从性.
出处 《山西医科大学学报》 CAS 2014年第9期817-820,共4页 Journal of Shanxi Medical University
基金 新疆维吾尔自治区科技支撑计划基金资助项目(20333117)
  • 相关文献

参考文献13

  • 1Zhou Z,Hu D.An epidemiological study on the prevalence of atrial fibrillation in the Chinese population of China's Mainland[J].J Epidemio1,2008,18:209-216.
  • 2Chugh SS,Havmoeller R,Narayanan K,et al.Worldwide epidemiology of atrial fibrillation:a global burden of disease 2010 study[J].Circulation,2014,129:837-847.
  • 3Fuster V,Rydén LE,Cannom DS,et al.ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation executive summary:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines[J].Circulation,2006,114:700-752.
  • 4Ouyang F,Tilz R,Chun J,et al.Long-term results of catheter ablation in paroxysmal atrial fibrillation:lessons from a 5-year follow-up[J].Circulation,2010,122:2368-2377.
  • 5Weerasooriya R,Khairy P,Litalien J,et al.Catheter ablation for atrial fibrillation:are results maintained at 5 years of follow-up[J].J Am Coll Cardio1,2011,57:160-166.
  • 6心房颤动抗凝治疗中国专家共识[J].中华内科杂志,2012,51(11):916-921. 被引量:139
  • 7Bouzas-Mosquera A,Peteiro J,Broullon FJ,et al.Effect of atrial fibrillation on outcome in patients with known or suspected coronary artery disease referred for exercise stress testing[J].Am J Cardiol,2010,105:1207-1211.
  • 8Lopes RD,White JA,Atar D,et al.Incidence,treatment,and out-comes of atrial fibrillation complicating non-ST-segment elevation acute coronary syndromes[J].Int J Cardiol,2013,168:2510-2517.
  • 9Giglioli C,Minelli M,Chiostri M,et al.Prognostic impact of atrial fibrillation occurrence in patients with non-ST-elevation acute coronary syndromes:is dysrhythmia duration a parameter to focus on[J]? Intern Emerg Med,2013,8:757-760.
  • 10戚文航.中国部分地区心房颤动住院病例回顾性调查[J].中华心血管病杂志,2003,31(12):913-916. 被引量:380

二级参考文献12

  • 1周自强,胡大一,陈捷,张仁汉,李奎宝,赵秀丽.中国心房颤动现状的流行病学研究[J].中华内科杂志,2004,43(7):491-494. 被引量:1401
  • 2PedersenOD,BrendorpB,KoberL ,etal.Prevalence,prognosticsignificance,andtreatmentofatrialfibrillationincongestiveheartfailurewith particularreference to the DIAMOND CH Fstudy[].Congestive Heart Failure.2003
  • 3GoAS ,,HylekEM,PhillipsKA ,etal.Prevalenceofdiagnosedatrialfibrillationinadults:nationalimplicationsforrhythmmanagementandstroke preventionTheanticoagulationandriskfactorsinatrialfibrillaiton(ATRIA)study[].The Journal of The American Medical Association.2001
  • 4SinghBN.Atrialfibrillation:epidemiologicconsiderationsandrationalforconversionandmaintenanceofsinusrhythm[].JCardiovascPharmacolTher.2003
  • 5LehtoM,KalaR.Persistentatrialfibrillation:apopulationbasedstudyofpatientswiththeirfirstcardioversion[].International Journal of Cardiology.2003
  • 6BjerregaardP,BaileyWB,RobinsonSE ,etal.Ratecontrolinpatientswithchronicatrialfibrillation[].The American Journal of Cardiology.2004
  • 7HohnloserSH,KuckKH,LilienthalJ.Rhythmorratecontrolinatrialfibrillagtion pharmacologicalinterventioninatrialfibrillation(PIAF ):arandomizedtrial[].The Lancet.2000
  • 8CarlssonJ,MiketicS,WindelerJ,etal.Randomizedtrialofrate controlversusrhythm controlinpersistentatrialfibrillation(STAF)[].Journal of the American College of Cardiology.2003
  • 9StellbrinkC,NixdorffU,HofmannT ,etal.Safetyandefficacyofenoxaparincomparedwithunfractionatedheparinandoralanticoagulantsfor preventionofthromboemboliccomplicationsincardioversionofnonvalvularatrialfibrillation[].Circulation.2004
  • 10PearceLA,HartRG,HalperinJL.Assesmentofthreeschemesforstratifyingstrokeriskin patientswithnonvalvularatrialfibrillation[].The American Journal of The Medical Sciences.2000

共引文献532

同被引文献20

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部